Viewing Study NCT02194595


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-02-27 @ 10:38 AM
Study NCT ID: NCT02194595
Status: COMPLETED
Last Update Posted: 2022-04-11
First Post: 2014-07-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Sponsor: Mount Sinai Hospital, Canada
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None type 2 diabetes View
None beta-cell function View
None GLP-1 View
None insulin View